Cite
STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applications.
MLA
Xu, Cheng, et al. “STING Agonist-Loaded Mesoporous Manganese-Silica Nanoparticles for Vaccine Applications.” Journal of Controlled Release, vol. 357, May 2023, pp. 84–93. EBSCOhost, https://doi.org/10.1016/j.jconrel.2023.03.036.
APA
Xu, C., Dobson, H. E., Yu, M., Gong, W., Sun, X., Park, K. S., Kennedy, A., Zhou, X., Xu, J., Xu, Y., Tai, A. W., Lei, Y. L., & Moon, J. J. (2023). STING agonist-loaded mesoporous manganese-silica nanoparticles for vaccine applications. Journal of Controlled Release, 357, 84–93. https://doi.org/10.1016/j.jconrel.2023.03.036
Chicago
Xu, Cheng, Hannah E. Dobson, Mengjie Yu, Wang Gong, Xiaoqi Sun, Kyung Soo Park, Andrew Kennedy, et al. 2023. “STING Agonist-Loaded Mesoporous Manganese-Silica Nanoparticles for Vaccine Applications.” Journal of Controlled Release 357 (May): 84–93. doi:10.1016/j.jconrel.2023.03.036.